Skip to main content
Livermore
Livermore
ZHEN

Context Therapeutics Inc.

CNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001842952

No open-market purchases or sales by Context Therapeutics Inc. insiders were filed in the last 90 days; 79 institutions reported holding it in 13F filings for Q2 2026, worth $34.8M in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Context Therapeutics Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+10 vs. Q3 2024
Shares held
72.8M
+16.1M (+28.4%) vs. Q3 2024
Total value
$76.4M
−$34.7M (−31.2%) vs. Q3 2024
New holders
14
15 more added
Sold out
4
12 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CNTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 52 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 19 institutionsQ1 2022: 16 institutionsQ2 2022: 20 institutionsQ3 2022: 24 institutionsQ4 2022: 24 institutionsQ1 2023: 22 institutionsQ2 2023: 22 institutionsQ3 2023: 23 institutionsQ4 2023: 24 institutionsQ1 2024: 25 institutionsQ2 2024: 34 institutionsQ3 2024: 42 institutionsQ4 2024: 52 institutionsQ1 2025: 42 institutionsQ2 2025: 39 institutionsQ3 2025: 37 institutionsQ4 2025: 43 institutionsQ1 2026: 60 institutionsQ2 2026: 79 institutions
Value heldQ4 2024: $76.4M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $9.44MQ1 2022: $6.30MQ2 2022: $6.32MQ3 2022: $4.59MQ4 2022: $2.55MQ1 2023: $722.6KQ2 2023: $3.58MQ3 2023: $3.89MQ4 2023: $4.02MQ1 2024: $5.43MQ2 2024: $114.3MQ3 2024: $111.2MQ4 2024: $76.4MQ1 2025: $43.7MQ2 2025: $45.0MQ3 2025: $66.8MQ4 2025: $96.0MQ1 2026: $194.6MQ2 2026: $34.8M
Institutions holding CNTX and their total value by quarter
QuarterHoldersValue
Q2 202679$34.8M
Q1 202660$194.6M
Q4 202543$96.0M
Q3 202537$66.8M
Q2 202539$45.0M
Q1 202542$43.7M
Q4 202452$76.4M
Q3 202442$111.2M
Q2 202434$114.3M
Q1 202425$5.43M
Q4 202324$4.02M
Q3 202323$3.89M
Q2 202322$3.58M
Q1 202322$722.6K
Q4 202224$2.55M
Q3 202224$4.59M
Q2 202220$6.32M
Q1 202216$6.30M
Q4 202119$9.44M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Context Therapeutics Inc.; share changes are against Q3 2024.

Institutions holding CNTX in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
MPM Oncology Impact Management LP14,705,882$15.4M2.19%+14,705,882New
Avidity Partners Management LP7,477,200$7.85M0.78%+60,045+0.8%Added
Deep Track Capital, LP7,419,355$7.79M0.29%00.0%Unchanged
Nextech Invest AG7,419,355$7.79M1.26%00.0%Unchanged
Blue Owl Capital Holdings LP6,357,928$6.68M1.58%+946,638+17.5%Added
Great Point Partners LLC4,683,711$4.92M2.32%−2,251,271−32.5%Reduced
Franklin Resources Inc4,003,380$4.20M0.00%+2,149,392+115.9%Added
Vanguard Group Inc3,255,463$3.42M0.00%−489,498−13.1%Reduced
Blackstone Group Inc.2,440,330$2.56M0.01%00.0%Unchanged
Nantahala Capital Management, LLC1,935,484$2.03M0.14%00.0%Unchanged
Alyeska Investment Group, L.P.1,663,355$1.75M0.01%−3000.0%Reduced
Ally Bridge Group (NY) LLC1,576,762$1.66M1.42%−180,762−10.3%Reduced
Woodline Partners LP1,361,350$1.43M0.01%+6680.0%Added
Sio Capital Management, LLC1,328,352$1.39M0.39%00.0%Unchanged
Affinity Asset Advisors, LLC1,015,340$1.07M0.17%−305,813−23.1%Reduced
Allostery Investments LP950,166$997.7K1.96%+950,166New
BlackRock, Inc.912,405$958.0K0.00%+63,435+7.5%Added
UBS Group AG699,129$734.1K0.00%+697,412+40,618.1%Added
Geode Capital Management, LLC628,729$660.5K0.00%+52,830+9.2%Added
ADAR1 Capital Management, LLC351,094$368.6K0.08%−22,741−6.1%Reduced
Renaissance Technologies LLC338,435$355.4K0.00%+272,435+412.8%Added
Qube Research & Technologies Ltd322,838$339.0K0.00%+219,433+212.2%Added
UBS Oconnor LLC308,758$324.2K0.01%00.0%Unchanged
Marshall Wace, LLP203,286$213.5K0.00%+203,286New
Millennium Management LLC178,718$187.7K0.00%+34,835+24.2%Added
Walleye Capital LLC166,306$174.6K0.00%+56,651+51.7%Added
State Street Corp152,607$160.2K0.00%+40,700+36.4%Added
HighTower Advisors, LLC125,852$132.1K0.00%00.0%Unchanged
Northern Trust Corp113,565$119.2K0.00%−58,946−34.2%Reduced
Mill Creek Capital Advisors, LLC104,631$109.9K0.00%00.0%Unchanged
Velan Capital Investment Management LP90,000$94.5K0.08%−1,200,323−93.0%Reduced
Landscape Capital Management, L.L.C.90,000$94.5K0.01%+90,000New
Clear Harbor Asset Management, LLC57,804$60.7K0.00%+21,804+60.6%Added
Citigroup Inc54,454$57.2K0.00%+9,675+21.6%Added
Aster Capital Management (DIFC) Ltd52,792$55.4K0.02%00.0%Unchanged
Shay Capital LLC50,000$52.5K0.01%+50,000New
Citadel Advisors LLC29,900$31.4K0.00%+29,900New
Jane Street Group, LLC27,395$28.8K0.00%+27,395New
Gsa Capital Partners LLP27,122$28.0K0.00%+27,122New
Cubist Systematic Strategies, LLC22,710$23.8K0.00%+22,710New
Caxton Corp18,403$19.3K0.12%00.0%Unchanged
Acadian Asset Management LLC16,668$17.0K0.00%+16,668New
Virtu Financial LLC11,638$12.0K0.00%+11,638New
Advisor Group Holdings, Inc.10,500$11.0K0.00%+10,000+2,000.0%Added
Susquehanna International Group, LLP10,185$10.7K0.00%−44,026−81.2%Reduced
Cerity Partners LLC10,000$10.5K0.00%00.0%Unchanged
United Capital Management of KS, Inc.10,000$10.5K0.00%+10,000New
Bank of America Corp6,257$6.57K0.00%−3,935−38.6%Reduced
Tower Research Capital LLC (TRC)934$9810.00%−6,221−86.9%Reduced
Morgan Stanley227$2380.00%+227New
JPMorgan Chase & Co166$1740.00%−7−4.0%Reduced
SBI Securities Co., Ltd.113$1190.00%+113New
Y-Intercept (Hong Kong) Ltd0$00.00%−45,635−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−43,200−100.0%Sold out
Two Sigma Investments, LP0$00.00%−13,844−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−200−100.0%Sold out